Vidaza and hypotension Patient Reports February 11, 2012

Vidaza Side Effects Report #5422042-X
Vidaza side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 80 years of age, weighting 145.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, carotid arteriosclerosis, haemoglobin decreased, heart rate irregular, hypotension, iron overload, local swelling, loss of consciousness, pyrexia. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ENALAPRIL, METOPROLOL TARTRATE, ASPIRIN, DEFERASIROX. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5229612-2
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 18, 2007. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: coma, dialysis , haemoglobin decreased, haemorrhage, hypotension, leukopenia, pneumonia . Vidaza dosage: 75 MG/M2 (130 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with COUMADIN, LIPITOR, DIGITEX, ATACAND, ARANESP. Patient was hospitalized. Patient died on 02/16/2006.

Vidaza Side Effects Report #5286019-X
Vidaza side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis , sputum discoloured, sputum purulent. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.

Vidaza Side Effects Report #5193880-6
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 19, 2006. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, hypoxia, interstitial lung disease, supraventricular tachycardia. Vidaza dosage: (85 MG, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with TOPROL, FOLTX, ZOLOFT, CARDURA, ZYRTEC, ARANESP. Patient was hospitalized. Patient died on 10/23/2006.


Vidaza Side Effects Report #4867503-7
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 08, 2005. Female patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, injection site haemorrhage, injection site pain, intestinal ischaemia, multi-organ failure, renal failure, respiratory failure, sepsis , thrombosis mesenteric vessel. Vidaza dosage: 75 MG/M2 (DAILY X 5. Patient died on 08/23/2005.

Vidaza Side Effects Report #5422150-3
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Aug 03, 2007. Male patient, 55 years of age, weighting 149.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial flutter, chest x-ray abnormal, diarrhoea, disease recurrence, hypertension, hypotension, pyrexia, tachycardia. Vidaza dosage: 135 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, CIPROFLOXACIN, ACYCLOVIR, ALLOPURINOL, PENICILLIN V, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5942302-3
Vidaza side effect was reported by a Consumer or non-health professional from SPAIN on Oct 21, 2008. Male patient, weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, colitis ischaemic, hypotension, renal failure. Vidaza dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, VANCOMYCIN, IMIPENEM, CASPOFUNGIN, VITAMIN B6, VORICONAZOLE, MAGNESIUM METAMIZOLE. Patient was hospitalized. Patient died on 09/21/2008.

Vidaza Side Effects Report #5913565-5
Vidaza side effect was reported by a Physician from SPAIN on Sept 29, 2008. Male patient, 75 years of age, weighting 149.9 lb, was diagnosed with fibrosis, myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, colitis ischaemic, hypotension, renal failure. Vidaza dosage: (75 MG/M2, X7 DAILY, SUBCUTANEOUS). During the same period patient was treated with TRANEXAMIC ACID, VANCOMYCIN, IMIPENEM, CASPOFUNGIN, VITAMIN B6, VORICONAZOLE, MAGNESIUM METAMIZOLE. Patient died on 09/21/2008.

Vidaza Side Effects Report #5228738-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiopulmonary failure, culture urine positive, enterococcal infection, hypotension, neutropenic sepsis, no therapeutic response, pericarditis, sinus tachycardia. Vidaza dosage: 132.75 MG (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/08/2007.